The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Regulation of α-synuclein by chaperones in mammalian cells
Open accessAbstract
Neurodegeneration in patients with Parkinson's disease is correlated with the occurrence of Lewy bodies-intracellular inclusions that contain aggregates of the intrinsically disordered protein α-synuclein 1. The aggregation propensity of α-synuclein in cells is modulated by specific factors that include post-translational modifications 2,3, Abelson-kinase-mediated phosphorylation 4,5 and interactions with intracellular machineries such as molecular chaperones, although the underlying mechanisms are unclear 6-8. Here we systematically characterize the interaction of molecular chaperones with α-synuclein in vitro as well as in cells at the atomic level. We find that six highly divergent molecular chaperones commonly recognize a canonical motif in α-synuclein, consisting of the N terminus and a segment around Tyr39, and hinder the aggregation of α-synuclein. NMR experiments 9 in cells show that the same transient interaction pattern is preserved inside living mammalian cells. Specific inhibition of the interactions between α-synuclein and the chaperone HSC70 and members of the HSP90 family, including HSP90β, results in transient membrane binding and triggers a remarkable re-localization of α-synuclein to the mitochondria and concomitant formation of aggregates. Phosphorylation of α-synuclein at Tyr39 directly impairs the interaction of α-synuclein with chaperones, thus providing a functional explanation for the role of Abelson kinase in Parkinson's disease. Our results establish a master regulatory mechanism of α-synuclein function and aggregation in mammalian cells, extending the functional repertoire of molecular chaperones and highlighting new perspectives for therapeutic interventions for Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that Hsp90 has a holdase function for these proteins by binding and protecting them from aggregation (69).”
From Client binding shifts the populations of dynamic Hsp90 conformations through an allosteric network (2021) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C., Oueslati, A., & Masliah, E. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3406 · Cited by 1,684
Molecular Chaperone Functions in Protein Folding and Proteostasis
Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,545
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Shahmoradian, S. H., Lewis, A. J., Genoud, C., Hench, J., Moors, T. E., Navarro, P. P., Castaño‐Díez, D., Schweighauser, G., Graff-Meyer, A., Goldie, K. N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0423-2 · Cited by 1,017
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 911
Structural disorder of monomeric α-synuclein persists in mammalian cells
Theillet, F., Binolfi, A., Bekei, B., Martorana, A., Rose, H. M., Stuiver, M., Verzini, S., Lorenz, D., van Rossum, M., Goldfarb, D., et al. (2016) · Nature · doi:10.1038/nature16531 · Cited by 895
Rüdiger, S., Germeroth, L., Schneider‐Mergener, J., & Bukau, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1501 · Cited by 815
Self-citationComposition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schäfer, C., Rammner, B., Koo, S. J., Claßen, G. A., Krauss, M., Haucke, V., et al. (2014) · Science · doi:10.1126/science.1252884 · Cited by 770
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Fusco, G., Chen, S. W., Williamson, P. T. F., Cascella, R., Perni, M., Jarvis, J. A., Cecchi, C., Vendruscolo, M., Chiti, F., Cremades, N., et al. (2017) · Science · doi:10.1126/science.aan6160 · Cited by 665
Park, J.-S., Davis, R. L., & Sue, C. M. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0829-3 · Cited by 516
Regulation of the c-Abl and Bcr–Abl tyrosine kinases
Hantschel, O. D., & Superti‐Furga, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1280 · Cited by 500
Surface tension of amino acid solutions: A hydrophobicity scale of the amino acid residues
Bull, H. B., & Breese, K. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(74)90352-x · Cited by 461
Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins
Ferbitz, L., Maier, T., Patzelt, H., Bukau, B., Deuerling, E., & Ban, N. (2004) · Nature · doi:10.1038/nature02899 · Cited by 419
Human Hsp70 Disaggregase Reverses Parkinson’s-Linked α-Synuclein Amyloid Fibrils
Gao, X., Carroni, M., Nussbaum-Krammer, C. I., Mogk, A., Nillegoda, N. B., Szlachcic, A., Guilbride, D. L., Saibil, H. R., Mayer, M. P., & Bukau, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.012 · Cited by 404
Hsp90-Tau complex reveals molecular basis for specificity in chaperone action
Karagöz, G. E., Duarte, A. M. S., Akoury, E., Ippel, H., Biernat, J., Morán Luengo, T., Radli, M., Didenko, T., Nordhues, B. A., Veprintsev, D. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.037 · Cited by 318
Self-citationStructural basis for protein antiaggregation activity of the trigger factor chaperone.
Saio, T., Guan, X., Rossi, P., Economou, A., & Kalodimos, C. G. (2014) · Science · doi:10.1126/science.1250494 · Cited by 289
Dedmon, M. M., Christodoulou, J., Wilson, M. R., & Dobson, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413024200 · Cited by 246
Mahul‐Mellier, A., Fauvet, B., Gysbers, A. M., Dikiy, I., Oueslati, A., Georgeon, S., Lamontanara, A. J., Bisquertt, A., Eliezer, D., Masliah, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt674 · Cited by 227
Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
Maltsev, A. S., Ying, J., & Bax, A. (2012) · Biochemistry · doi:10.1021/bi300642h · Cited by 217
Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration
Brahmachari, S., Ge, P., Lee, S. H., Kim, D., Karuppagounder, S. S., Kumar, M., Mao, X., Shin, J. H., Lee, Y., Pletniková, O., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85456 · Cited by 202
Macromolecular Crowding in the Escherichia coli Periplasm Maintains α-Synuclein Disorder
McNulty, B. C., Young, G. B., & Pielak, G. J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.033 · Cited by 184
Finn, T., Nunez, A. C., Sunde, M., & Easterbrook‐Smith, S. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372961 · Cited by 165
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Reeve, A. K., Grady, J. P., Cosgrave, E., Bennison, E., Chen, C., Hepplewhite, P. D., & Morris, C. M. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0044-6 · Cited by 157
Korndörfer, I. P., Dommel, M. K., & Skerra, A. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb828 · Cited by 143
Falsone, S. F., Kungl, A. J., Rek, A., Cappai, R., & Zangger, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057240 · Cited by 137
Burmann, B. M., Wang, C., & Hiller, S. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2677 · Cited by 132
Self-citationChaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by Hip
Roodveldt, C., Bertoncini, C. W., Andersson, A., van der Goot, A. T., Hsu, S. D., Fernández-Montesinos, R., de Jong, J., van Ham, T. J., Nollen, E. A. A., Pozo, D., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.298 · Cited by 129
Hsc70 Protein Interaction with Soluble and Fibrillar α-Synuclein
Pemberton, S., Madiona, K., Pieri, L., Kabani, M., Bousset, L., & Melki, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261321 · Cited by 114
Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites
Binolfi, A., Limatola, A., Verzini, S., Kosten, J., Theillet, F., Rose, H. M., Bekei, B., Stuiver, M., van Rossum, M., & Selenko, P. (2016) · Nature Communications · doi:10.1038/ncomms10251 · Cited by 111
A molecular mechanism of chaperone-client recognition
He, L., Sharpe, T., Mazur, A., & Hiller, S. (2016) · Science Advances · doi:10.1126/sciadv.1601625 · Cited by 78
Self-citationWilson, M. R., Dedmon, M. M., Christodoulou, J. C., & Dobson, C. M. (2005) · Research Online (University of Wollongong) · Cited by 77
Kosten, J., Binolfi, A., Stuiver, M., Verzini, S., Theillet, F., Bekei, B., van Rossum, M., & Selenko, P. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5002254 · Cited by 66
Molecular Chaperones and Co-Chaperones in Parkinson Disease
Dimant, H., Ebrahimi‐Fakhari, D., & McLean, P. J. (2012) · The Neuroscientist · doi:10.1177/1073858412441372 · Cited by 55
Mahul‐Mellier, A., Altay, M. F., Burtscher, J., Maharjan, N., Ait‐Bouziad, N., Chiki, A., Vingill, S., Wade‐Martins, R., Holton, J. L., Strand, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/500058 · Cited by 45
Novel subcellular localization for α-synuclein: possible functional consequences
Guardia-Laguarta, C., Area-Gomez, E., Schon, E. A., & Przedborski, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00017 · Cited by 44
Two‐Dimensional Crowding Uncovers a Hidden Conformation of α‐Synuclein
Banerjee, P. R., Moosa, M. M., & Deniz, A. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606963 · Cited by 31
Cited by
Sorted by citations
Mitochondrial dysfunction: mechanisms and advances in therapy
Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,382
Mechanisms and pathology of protein misfolding and aggregation
Louros, N. N., Schymkowitz, J. W. H., & Rousseau, F. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00647-2 · Cited by 271
Molecular dissection of amyloid disaggregation by human HSP70
Wentink, A. S., Nillegoda, N. B., Feufel, J., Ubartaitė, G., Schneider, C. P., Rios, P. D. L., Hennig, J., Barducci, A., & Bukau, B. (2020) · Nature · doi:10.1038/s41586-020-2904-6 · Cited by 231
Vidović, M., & Rikalović, M. (2022) · Cells · doi:10.3390/cells11111732 · Cited by 214
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Oliveira, L. M. A., Gasser, T., Edwards, R. H., Zweckstetter, M., Melki, R., Stefanis, L., Lashuel, H. A., Sulzer, D., Vekrellis, K., Halliday, G. M., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00203-9 · Cited by 174
Metadata
- Authors
- Burmann, B. M., Gerez, J. A., Matečko-Burmann, I., Campioni, S., Kumari, P., Ghosh, D., Mazur, A., Aspholm, E. E., Šulskis, D., Wawrzyniuk, M., Bock, T., Schmidt, A., Rüdiger, S. G. D., Riek, R., & Hiller, S.
- Affiliations
- University of Basel (CH)
- ETH Zurich (CH)
- Wallenberg Centre for Molecular and Translational Medicine (SE)
- Utrecht University (NL)
- Corresponding author
- Burmann, Björn M.
- Riek, Roland
- Hiller, Sebastian
- ORCID
- Venue
- Nature
- Published
- 2019-12-04
- Volume
- 577
- Issue
- 7788
- Pages
- 127-132
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6930850
- OpenAlex
- W2992154881
- Cited by
- 255
- References
- 38
- Citations by year
- 2026: 12 · 2025: 32 · 2024: 38 · 2023: 56 · 2022: 53 · 2021: 36 · 2020: 27 · 2019: 1
- FWCI
- 20.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- edoc (University of Basel) (acceptedVersion)
- DORA Empa (Swiss Federal Laboratories for Materials Science and Technology (Empa)) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Gothenburg University Publications Electronic Archive (Gothenburg University) (submittedVersion)
- edoc (University of Basel)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (166426, 148238, 164425, 128419)
- Vetenskapsrådet
- Göteborgs Universitet
- Wallenberg Centre for Molecular and Translational Medicine
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, molecular chaperones, Parkinson's disease, protein aggregation, Hsc70, HSP90, HSP90β, Abelson kinase, mitochondrial localization, Lewy bodies, intrinsically disordered proteins, neurodegeneration
- MeSH terms
- Cell Survival, Humans, Magnetic Resonance Spectroscopy, Protein Processing, Post-Translational, Molecular Chaperones, alpha-Synuclein, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
